There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Patients First Act of 2018

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes.


Actions Overview (1)

Date Actions Overview
05/24/2018Introduced in Senate

All Actions (1)

Date All Actions
05/24/2018Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Action By: Senate

Cosponsors (5)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Daines, Steve [R-MT]* 05/24/2018
Sen. Blunt, Roy [R-MO]* 05/24/2018
Sen. Lankford, James [R-OK]* 05/24/2018
Sen. Inhofe, James M. [R-OK] 06/11/2018
Sen. Hyde-Smith, Cindy [R-MS] 07/31/2018

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Health, Education, Labor, and Pensions05/24/2018 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (1)


Latest Summary (1)

There is one summary for S.2956. View summaries

Shown Here:
Introduced in Senate (05/24/2018)

Patients First Act of 2018

This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that the techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.

HHS must issue guidelines to ensure that any research (including any clinical trial) supported under this bill: (1) is clearly consistent with the standards established in this bill, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients.

HHS must report on peer reviewed stem cell research proposals that were not funded.